Atlas Trials

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer

Clinical trial NCT01749956 · COMPLETED

Trial details

NCT number
NCT01749956
Sponsor
SCRI Development Innovations, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2013-01-01
Primary completion
2015-09-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.